Comet Diagnostics announcement, the company received a notice of equity changes issued by shareholders Shanghai Peixi and its concerted action person HJ CAPITAL on September 3. From January 12, 2023 to September 2, 2024, Shanghai Peixi and its concerted action person collectively reduced their shares in the company by 4,040,104 shares, accounting for 1.01% of the total share capital. Before this equity change, Shanghai Peixi and its concerted action person collectively held 39,224,454 shares of the company, accounting for 9.78% of the total share capital. After the change, they collectively hold 35,184,350 shares of the company, accounting for 8.77% of the total share capital. This equity change will not result in a change of the company's controlling shareholder or actual controller.
科美诊断：股东上海沛禧及其一致行动人HJ CAPITAL持股比例减少至8.77%
Cormorant diagnosis: Shareholder Shanghai Peixi and its concerted action person HJ CAPITAL's shareholding ratio decreased to 8.77%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.